Shaji K. Kumar, MD | Authors


Should Frontline Myeloma Treatment Include a 3- or 4-Drug Regimen?

October 29, 2020

Shaji K. Kumar, MD, addresses an important unanswered question that remains in the treatment landscape of newly diagnosed multiple myeloma, which is whether 3- or 4-drug regimens should be used in the frontline setting.